InvestorsHub Logo
icon url

1776club

04/29/22 1:48 PM

#13605 RE: dia76ca #13604

I am Hopeful. If I remember, her projects were under $150 Million. These are the last two shown below. The problem that I see, is none of these people in management have been involved in a Multinational Company having so many Subsidiaries, Partnerships, Trials and Large Construction projects being juggled at the same time. Just looking at the new facility alone is a daunting undertaking that can take a year or more after the keys are handed out to move equipment into, buy new equipment and install, correct found problems and once that is all done get the FDA to approve both Medical Devices and Pharmaceutical production by performing inspections (cGMPs) of the facility for pre and post market approval. The way I see it COVI-STIX sales and approvals and sales outside of the company is where the next 9 - 14 months depend on. Is a EUA really needed for one more covid test in the US at this point in time...I don't think so.

Altimmune has raised a total of $51.4M in funding over 4 rounds. Their latest funding was raised on Aug 21, 2019 from a Grant round.
Altimmune is registered under the ticker
NASDAQ:ALT
.
Altimmune is funded by 5 investors. Biomedical Advanced Research and Development Authority (BARDA) and HealthCap are the most recent investors.
Altimmune has acquired 3 organizations. Their most recent acquisition was Spitfire Pharma on Jul 9, 2019. They acquired Spitfire Pharma for $93M.

Isarna Therapeutics has raised a total of $124.2M in funding over 7 rounds. Their latest funding was raised on Apr 24, 2014 from a Venture - Series Unknown round.
Isarna Therapeutics is funded by 6 investors. Global Asset Fund and MIG are the most recent investors.

https://www.fda.gov/drugs/pharmaceutical-quality-resources/facts-about-current-good-manufacturing-practices-cgmps?msclkid=1fc6f799c7e411ec85d6da76ecc2bc48
icon url

FitzyP33

04/30/22 11:54 AM

#13609 RE: dia76ca #13604

I'd like to think that the new CFO carefully analyzed the situation at SRNE and decided to become CFO because it's a real opportunity rather than a place to earn a little bit of coin while she's figuring out her next gig (if there is one). After all she is 66 years old and this may be her last job before retiring. I just don't see how Henry could attract a world class CFO given the situation he is in. The whole situation boggles the mind. At least my mind. As a former CFO myself I wouldn't touch that job with a 10 foot pole. There's just simply too much downside. What if some of these shareholder lawsuits gain traction. The last CFO is dead (RIP) the previous CFO is God knows where (hiding?) so she's left to explain the finances of the company. She can hide behind I just got here I suppose, but eventually that will break down in court. Seems like soooo much downside and not much upside.